Literature DB >> 19653046

Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients.

Kandace P McGuire1, Alfredo A Santillan, Paramjeet Kaur, Tammi Meade, Jateen Parbhoo, Morgan Mathias, Corinne Shamehdi, Michelle Davis, Daniel Ramos, Charles E Cox.   

Abstract

BACKGROUND: The equivalency of survival between mastectomy and breast conservation therapy (BCT) has long been established, resulting in two decades of predominant BCT. Recently, surgeons have recognized a trend toward increasing mastectomy. Institutional trends of mastectomy and BCT were reviewed, confirming this perception in the surgical treatment of breast cancer. This report evaluates the factors that influence patient decisions to choose surgical therapies.
METHODS: Patients who underwent mastectomy or BCT for invasive and in situ breast cancer were identified upon retrospective review of a prospectively accrued breast cancer database between 1994 and 2007. Univariate and multivariate logistic regression analysis were used to estimate the odds ratio (OR) of the association between mastectomy and patients' clinicopathologic characteristics.
RESULTS: Of the 5,865 patients, 3,736 underwent BCT and 2,129 underwent mastectomy. The overall surgical volume decreased during the study period. Mastectomy rates during the periods of 1994-1998, 1999-2003, and 2004-2007 were 33%, 33%, and 44%, respectively (P < 0.01). Immediate reconstruction rates decreased during the same time periods from 16%, 5%, and 7%, respectively (P < 0.01). On logistic regression analysis, gender, age < 40 years, increase tumor size, and lymphovascular invasion were significant independent predictors of mastectomy. The mastectomy rate increased during the period 1999-2003 (OR 1.2) and during 2004-2007(OR 1.8).
CONCLUSIONS: The perception of an increasing choice toward mastectomy has been confirmed at this institution. Possible reasons are younger population with higher lifetime risk, higher stage disease, and more biologically aggressive or diffuse tumors. Patient preference, fear of genetic or recurrence risk, and "intangible" factors seem to shift decisions toward mastectomy.

Entities:  

Mesh:

Year:  2009        PMID: 19653046     DOI: 10.1245/s10434-009-0635-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  86 in total

Review 1.  United States trends in the surgical treatment of primary breast cancer.

Authors:  Todd M Tuttle; Natasha M Rueth; Andrea Abbott; Beth A Virnig
Journal:  World J Surg       Date:  2012-07       Impact factor: 3.352

Review 2.  Contralateral prophylactic mastectomy in breast cancer: what to discuss with patients.

Authors:  Giacomo Montagna; Monica Morrow
Journal:  Expert Rev Anticancer Ther       Date:  2020-02-28       Impact factor: 4.512

3.  Surgical attitudes toward preoperative breast magnetic resonance imaging in women with early-stage breast cancer.

Authors:  S D Mukherjee; N Hodgson; P J Lovrics; K Dhamanaskar; S Chambers; J Sussman
Journal:  Curr Oncol       Date:  2019-04-01       Impact factor: 3.677

Review 4.  Trends and controversies in multidisciplinary care of the patient with breast cancer.

Authors:  Laura S Dominici; Monica Morrow; Elizabeth Mittendorf; Jennifer Bellon; Tari A King
Journal:  Curr Probl Surg       Date:  2016-11-29       Impact factor: 1.909

5.  Use of a handheld terahertz pulsed imaging device to differentiate benign and malignant breast tissue.

Authors:  Maarten R Grootendorst; Anthony J Fitzgerald; Susan G Brouwer de Koning; Aida Santaolalla; Alessia Portieri; Mieke Van Hemelrijck; Matthew R Young; Julie Owen; Massi Cariati; Michael Pepper; Vincent P Wallace; Sarah E Pinder; Arnie Purushotham
Journal:  Biomed Opt Express       Date:  2017-05-09       Impact factor: 3.732

6.  Factors associated with the frequency of initial total mastectomy: results of a multi-institutional study.

Authors:  Heather Spencer Feigelson; Ted A James; Richard M Single; Adedayo A Onitilo; Erin J Aiello Bowles; Tom Barney; Jordan E Bakerman; Laurence E McCahill
Journal:  J Am Coll Surg       Date:  2013-03-13       Impact factor: 6.113

7.  Borderline atypical ductal hyperplasia/low-grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively.

Authors:  Christopher J Vandenbussche; Nagi Khouri; Eman Sbaity; Theodore N Tsangaris; Russell Vang; Armanda Tatsas; Ashley Cimino-Mathews; Pedram Argani
Journal:  Am J Surg Pathol       Date:  2013-06       Impact factor: 6.394

8.  Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States.

Authors:  Reshma Jagsi; Jing Jiang; Adeyiza O Momoh; Amy Alderman; Sharon H Giordano; Thomas A Buchholz; Steven J Kronowitz; Benjamin D Smith
Journal:  J Clin Oncol       Date:  2014-02-18       Impact factor: 44.544

9.  Exploring reasons for overuse of contralateral prophylactic mastectomy in Canada.

Authors:  J E Squires; S N Simard; S Asad; D Stacey; I D Graham; M Coughlin; M Clemons; J M Grimshaw; J Zhang; J M Caudrelier; A Arnaout
Journal:  Curr Oncol       Date:  2019-08-01       Impact factor: 3.677

10.  Mastectomies on the rise for breast cancer: "the tide is changing".

Authors:  Charles M Balch; Lisa K Jacobs
Journal:  Ann Surg Oncol       Date:  2009-07-31       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.